4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001209191-21-026064
Chief Medical Officer sold 4,000 shares at an average $33.86 ($135,445)
- Chief Medical Officer acquired 4,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Alland Leila · Chief Medical Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-04-07 | Exercise or conversion : show line 1 in the form | +4,000 | $3.90 | $15,600 | 4,000 | D |
| 2021-04-07 | Sale : show line 2 in the form | −3,972 | $33.86 | $134,481 | 28 | D |
| 2021-04-07 | Sale : show line 3 in the form | −28 | $34.42 | $964 | 0 | D |
| Open-market sales · 4,000 sh · avg $33.86 · $135,445 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-04-07 | Exercise or conversion : show line 4 in the form Employee Stock Option (right to buy) | −4,000 | 373,850 | D |
Loading xslF345X03/doc4.xml…